These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
199 related items for PubMed ID: 11009265
1. Effects of cilostazol on angiographic restenosis after coronary stent placement. Park SW, Lee CW, Kim HS, Lee NH, Nah DY, Hong MK, Kim JJ, Park SJ. Am J Cardiol; 2000 Sep 01; 86(5):499-503. PubMed ID: 11009265 [Abstract] [Full Text] [Related]
2. Effect of cilostazol on restenosis after coronary angioplasty and stenting in comparison to conventional coronary artery stenting with ticlopidine. Tanabe Y, Ito E, Nakagawa I, Suzuki K. Int J Cardiol; 2001 May 01; 78(3):285-91. PubMed ID: 11376832 [Abstract] [Full Text] [Related]
3. Randomized comparison of cilostazol versus ticlopidine hydrochloride for antiplatelet therapy after coronary stent implantation for prevention of late restenosis. Kamishirado H, Inoue T, Mizoguchi K, Uchida T, Nakata T, Sakuma M, Takayanagi K, Morooka S. Am Heart J; 2002 Aug 01; 144(2):303-8. PubMed ID: 12177649 [Abstract] [Full Text] [Related]
4. RACTS: a prospective randomized antiplatelet trial of cilostazol versus ticlopidine in patients undergoing coronary stenting: long-term clinical and angiographic outcome. Ge J, Han Y, Jiang H, Sun B, Chen J, Zhang S, Du Z, RACTS (Randomized Prospective Antiplatelet Trial of Cilostazol Versus Ticlopidine in Patients Undergoing Coronary Stenting) Trial Investigators. J Cardiovasc Pharmacol; 2005 Aug 01; 46(2):162-6. PubMed ID: 16044027 [Abstract] [Full Text] [Related]
8. Effect of cilostazol on in-stent neointimal hyperplasia after coronary artery stenting: a quantative coronary angiography and volumetric intravascular ultrasound study. Min PK, Jung JH, Ko YG, Choi D, Jang Y, Shim WH. Circ J; 2007 Nov 01; 71(11):1685-90. PubMed ID: 17965485 [Abstract] [Full Text] [Related]
10. Impact of cilostazol on restenosis after percutaneous coronary balloon angioplasty. Tsuchikane E, Fukuhara A, Kobayashi T, Kirino M, Yamasaki K, Kobayashi T, Izumi M, Otsuji S, Tateyama H, Sakurai M, Awata N. Circulation; 1999 Jul 06; 100(1):21-6. PubMed ID: 10393676 [Abstract] [Full Text] [Related]
11. Randomized comparison of cilostazol vs clopidogrel after drug-eluting stenting in diabetic patients--clilostazol for diabetic patients in drug-eluting stent (CIDES) trial. Ahn Y, Jeong MH, Jeong JW, Kim KH, Ahn TH, Kang WC, Park CG, Kim JH, Chae IH, Nam CW, Hur SH, Bae JH, Kim KY, Oh SK. Circ J; 2008 Jan 06; 72(1):35-9. PubMed ID: 18159096 [Abstract] [Full Text] [Related]
17. Debulking and stenting versus debulking only of coronary artery disease in patients treated with cilostazol (final results of ESPRIT). Tsuchikane E, Kobayashi T, Kobayashi T, Takeda Y, Otsuji S, Sakurai M, Awata N. Am J Cardiol; 2002 Sep 15; 90(6):573-8. PubMed ID: 12231079 [Abstract] [Full Text] [Related]
19. [The effects of post coronary stenting triple antiplatelet therapies on platelet functions]. Han YL, Su QF, Li Y, Kang J, Yan CH, Wang SL. Zhonghua Nei Ke Za Zhi; 2006 Aug 15; 45(8):635-8. PubMed ID: 17074146 [Abstract] [Full Text] [Related]